首页 | 本学科首页   官方微博 | 高级检索  
检索        

岩黄连总碱胶囊在健康受试者体内的药动学研究
引用本文:戴国梁,欧阳冰琛,王一清,陈闪闪,杨欣怡,许美娟,居文政,刁和芳.岩黄连总碱胶囊在健康受试者体内的药动学研究[J].中国医院药学杂志,2022,42(7):702-706.
作者姓名:戴国梁  欧阳冰琛  王一清  陈闪闪  杨欣怡  许美娟  居文政  刁和芳
作者单位:1. 南京中医药大学附属医院临床药理科, 江苏 南京 210029;2. 江苏弘典中药产业研究院有限公司, 江苏 南京 210042
基金项目:江苏省中医药领军人才(编号:SLJ0208);江苏省自然科学基金面上项目(编号:BK20181504,BK20211394)
摘    要:目的:建立LC-MS/MS法测定人血浆中脱氢卡维丁的浓度,研究不同剂量岩黄连总碱胶囊在中国健康受试者多次给药后的药动学.方法:采用随机、开放、多剂量给药设计的方法.16名健康志愿者随机分为2个剂量组(2 400 mg和3 200 mg),男女各半,每组8例,分别多次口服岩黄连总碱胶囊,每日1次,连续7 d,第7天在给药...

关 键 词:岩黄连总碱胶囊  脱氢卡维丁  人体  药动学  高效液相串联质谱
收稿时间:2021-07-20

Pharmacokinetics of Yanhuanglian total alkaloids capsules in healthy volunteers
DAI Guo-liang,OUYANG Bing-chen,WANG Yi-qing,CHEN Shan-shan,YANG Xin-yi,XU Mei-juan,JU Wen-zheng,DIAO He-fang.Pharmacokinetics of Yanhuanglian total alkaloids capsules in healthy volunteers[J].Chinese Journal of Hospital Pharmacy,2022,42(7):702-706.
Authors:DAI Guo-liang  OUYANG Bing-chen  WANG Yi-qing  CHEN Shan-shan  YANG Xin-yi  XU Mei-juan  JU Wen-zheng  DIAO He-fang
Institution:1. Department of Clinical Pharmacology, Affiliated Hospital of Nanjing University of Chinese Medicine, Jiangsu Nanjing 210029, China;2. Jiangsu Hongdian Research Institute of Traditional Chinese Medicine Industry Co. Ltd., Jiangsu Nanjing 210042, China
Abstract:OBJECTIVE To develop the LC-MS/MS method for the determination of dehydrocavidine in human plasma, and study pharmacokinetics of Yanhuanglian total alkaloids capsules at different doses with repeated oral administration in Chinese healthy volunteers.METHODS A randomized, open, multi-dose design was conducted. Sixteen healthy volunteers (with half males and half females) were randomized into two groups with eight cases in each (2 400 mg and 3 200 mg). The sixteen subjects were orally administrated with Yanhuanglian total alkaloids capsules, once a day for seven days. On the 7th day, the blood samples were collected at different time points after administration. The separation of plasma was performed on an Agilent ZORBAX SB-C18 column (3.0 mm×100 mm, 3.5 μm) after precipitated by acetonitrile with the mobile phase consisting of 0.2% formic acid (containing 1 mmol·L-1 ammonium formate)-acetonitrile (30∶70, V/V). Dehydrocavidine and dextromethorphan (IS) were detected by the MS system with an electrospray ionization (ESI) interface in positive ion mode. Multiple reaction monitoring (MRM) was used to monitor precursor to product ion transition of m/z 350.3→334.3 for dehydrocavidine and m/z 272.2→171.3 for IS. Pharmacokinetic parameters were calculated by WinNonlin 8.0 software.RESULTS The linear range of dehydrocavidine was 0.015-3 ng·mL-1. The lower limit of quantification was 0.015 ng·mL-1. The indicators of method validation were in line with the requirements. The main pharmacokinetic parameters of dehydrocavidine after oral administration of multiple doses of 2 400 mg and 3 200 mg were as follows, tmax were (1.75±1.04) h and (2.06±0.98) h, t1/2 were (31.59±17.32) h and (35.98±14.46) h, AUC0-t were (2.637±0.504)ng·h·mL-1 and (3.150±0.485) ng·h·mL-1, AUC0-∞ were (5.512±1.792) ng·h·mL-1 and (7.649±3.306) ng·h·mL-1, respectively.CONCLUSION The LC-MS/MS method is simple and sensitive, and can be successfully applied to the pharmacokinetic study of Yanhuanglian total alkaloids capsules in healthy Chinese volunteers.
Keywords:Yanhuanglian total alkaloids capsules  dehydrocavidine  human  pharmacokinetics  LC-MS/MS  
点击此处可从《中国医院药学杂志》浏览原始摘要信息
点击此处可从《中国医院药学杂志》下载免费的PDF全文
设为首页 | 免责声明 | 关于勤云 | 加入收藏

Copyright©北京勤云科技发展有限公司  京ICP备09084417号